These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12364609)

  • 21. Antisense c-myc effects on preimplantation mouse embryo development.
    Paria BC; Dey SK; Andrews GK
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10051-5. PubMed ID: 1279668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide.
    Khan I; Al-Awadi FM; Thomas N
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):199-207. PubMed ID: 11572597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of hybridization between synthetic oligodeoxynucleotides and RNA in living cells.
    Politz JC; Taneja KL; Singer RH
    Nucleic Acids Res; 1995 Dec; 23(24):4946-53. PubMed ID: 8559650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antisense oligonucleotides: tools of molecular genetics and therapeutic agents].
    Toulmé JJ; Verspieren P; Boiziau C; Loreau N; Cazenave C; Thuong NT
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():11-4. PubMed ID: 2264671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain.
    McCarthy MM; Schlenker EH; Pfaff DW
    Endocrinology; 1993 Aug; 133(2):433-9. PubMed ID: 8344188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming.
    Saetrom P
    Bioinformatics; 2004 Nov; 20(17):3055-63. PubMed ID: 15201190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.
    Sohail M; Hochegger H; Klotzbücher A; Guellec RL; Hunt T; Southern EM
    Nucleic Acids Res; 2001 May; 29(10):2041-51. PubMed ID: 11353073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
    Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S
    J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and purification of HIV-I p15NC protein in Escherichia coli.
    Ozturk DH; Erickson-Viitanen S
    Protein Expr Purif; 1998 Oct; 14(1):54-64. PubMed ID: 9758751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of oligo sequence and chemistry on the efficiency of oligodeoxyribonucleotide-mediated mRNA cleavage.
    Baker C; Holland D; Edge M; Colman A
    Nucleic Acids Res; 1990 Jun; 18(12):3537-43. PubMed ID: 2362806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ODNBase--a web database for antisense oligonucleotide effectiveness studies. Oligodeoxynucleotides.
    Giddings MC; Matveeva OV; Atkins JF; Gesteland RF
    Bioinformatics; 2000 Sep; 16(9):843-4. PubMed ID: 11108708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ reverse transcription for detection of hybridization between oligonucleotides and their intracellular targets.
    Politz JC; Singer RH
    Methods; 1999 Jul; 18(3):281-5. PubMed ID: 10454986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of BCL-2 suppression by antisense oligonucleotides on additional regulators of apoptosis compensatory change in non-targeted protein expression.
    Rubenstein M; Hollowell CM; Guinan P
    In Vivo; 2011; 25(5):725-32. PubMed ID: 21753125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of mRNA self-structure on hybridization: computational tools for antisense sequence selection.
    Toschi N
    Methods; 2000 Nov; 22(3):261-9. PubMed ID: 11071822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense oligodeoxynucleotide and ribozyme design.
    Probst JC
    Methods; 2000 Nov; 22(3):271-81. PubMed ID: 11071823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A selection strategy in plant transformation based on antisense oligodeoxynucleotide inhibition.
    Xie Z; Sundström JF; Jin Y; Liu C; Jansson C; Sun C
    Plant J; 2014 Mar; 77(6):954-61. PubMed ID: 24438514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines.
    Kim JW; Kim TE; Kim YK; Kim YW; Kim SJ; Lee JM; Kim IK; Namkoong SE
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):507-13. PubMed ID: 10645776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of HBx antisense oligodeoxynucleotide on formation of transplanted hepatocellular carcinoma in nude mice].
    Zhang J; Wang PJ; Yuan XD
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):38-41. PubMed ID: 19203450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.